The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease

Since 2005, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has invested significant funding and non-funding effort to accelerate research and drug development activity around the Parkinson disease (PD)-associated protein LRRK2. MJFF has spearheaded multiple public/private pre-competit...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmanabhan, Shalini, Fiske, Brian K., Baptista, Marco A.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466022/
https://www.ncbi.nlm.nih.gov/pubmed/32796584
http://dx.doi.org/10.3390/cells9081878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466022/
https://www.ncbi.nlm.nih.gov/pubmed/32796584
http://dx.doi.org/10.3390/cells9081878

Ejemplares similares